KTB Stock Analysis: Kontoor Brands | NYSE
Apparel Manufacturing | NYSE, USA | Market Cap: 4.005m USD | 12M Return: -5% | US50050N1037 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 44.5M
EPS Trend: 98.1%
Qual. Beats: 1
Rev. Trend: 80.2%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 7.4 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Kontoor Brands, Inc. (NYSE: KTB) is a lifestyle apparel company that designs, manufactures, procures, sells, and licenses apparel, footwear, and accessories primarily under the Wrangler, Lee, and Helly Hansen brands. It also licenses apparel under the Musto, Chic, and Rock & Republic names and reports through two operating segments: Wrangler and Lee. The company was incorporated in 2018 and is headquartered in Greensboro, North Carolina, with operations across the Americas, Europe, the Middle East, Africa, and Asia-Pacific.
Distribution is multi-channel, spanning mass merchants, outdoor and sporting goods stores, specialty and department stores, company-operated retail, online and digital marketplaces, and business-to-business workwear and uniform programs, delivered through both wholesale and direct-to-consumer channels. Kontoor is classified within the Consumer Discretionary sector (Apparel, Accessories & Luxury Goods) and combines heritage denim and workwear brands with a licensing model, which provides a mix of stable B2B/uniform revenue alongside more cyclical consumer apparel sales. Wrangler and Lee are long-established mass and Western/workwear labels, while the addition of Helly Hansen extends the portfolio into outdoor and performance apparel.
- Helly Hansen acquisition closes, expanding outdoor and international exposure
- Wrangler mass channel revenue pressured by soft denim demand at key retailers
- Cotton input cost inflation compresses gross margin guidance
| Net Income: 267.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 4.86 > 1.0 |
| NWC/Revenue: 16.97% < 20% (prev 24.80%; Δ -7.83% < -1%) |
| CFO/TA 0.17 > 3% & CFO 446.1m > Net Income 267.9m |
| Net Debt (1.34b) to EBITDA (422.0m): 3.18 < 3 |
| Current Ratio: 1.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.5m) vs 12m ago -0.86% < -2% |
| Gross Margin: 49.71% > 18% (prev 45.48%; Δ 4.23% > 0.5%) |
| Asset Turnover: 114.0% > 50% (prev 97.53%; Δ 16.52% > 0%) |
| Interest Coverage Ratio: 5.26 > 6 (EBIT TTM 369.6m / Interest Expense TTM 70.3m) |
| A: 0.20 (Total Current Assets 1.15b - Total Current Liabilities 627.3m) / Total Assets 2.67b |
| B: 0.11 (Retained Earnings 280.6m / Total Assets 2.67b) |
| C: 0.14 (EBIT TTM 369.6m / Avg Total Assets 2.69b) |
| D: 0.30 (Book Value of Equity 618.5m / Total Liabilities 2.05b) |
| Altman-Z'' = 2.87 = A |
| DSRI: 0.63 (Receivables 220.8m/304.8m, Revenue 3.07b/2.65b) |
| GMI: 0.91 (GM 45.48% / 49.71%) |
| AQI: 1.09 (AQ_t 0.48 / AQ_t-1 0.44) |
| SGI: 1.16 (Revenue 3.07b / 2.65b) |
| TATA: -0.07 (NI 267.9m - CFO 446.1m) / TA 2.67b) |
| Beneish M = -3.25 (Cap -4..+1) = AA |
As of October 23, 2026, the stock is trading at USD 77.78 with a total of 589,829 shares traded. Over the past week, the price has changed by +6.64%, over one month by +14.69%, over three months by -9.73% and over the past year by -4.97%.
Current recommended Stop Loss: 72.80 (which is 6.4% or 2.1 ATR below the current price).
Kontoor Brands has received a consensus analysts rating of 4.30. Therefore, it is recommended to buy KTB.
- StrongBuy: 6
- Buy: 2
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 98.2 | 26.3% |
P/E Trailing = 17.9169
P/E Forward = 14.4928
P/S = 1.1661
P/B = 5.8043
Revenue TTM = 3.07b USD
EBIT TTM = 369.6m USD
EBITDA TTM = 422.0m USD
Long Term Debt = 1.13b USD (from longTermDebt, last quarter)
Short Term Debt = 47.2m USD (from shortTermDebt, last quarter)
Debt = 1.40b USD (from shortLongTermDebtTotal, last quarter) + Leases 128.6m
Net Debt = 1.34b USD (calculated: Debt 1.40b - CCE 58.5m)
Enterprise Value = 5.35b USD (4.01b + Debt 1.40b - CCE 58.5m)
Interest Coverage Ratio = 5.26 (Ebit TTM 369.6m / Interest Expense TTM 70.3m)
EV/FCF = 12.64x (Enterprise Value 5.35b / FCF TTM 423.2m)
FCF Yield = 7.91% (FCF TTM 423.2m / Enterprise Value 5.35b)
FCF Margin = 13.79% (FCF TTM 423.2m / Revenue TTM 3.07b)
Net Margin = 8.73% (Net Income TTM 267.9m / Revenue TTM 3.07b)
Gross Margin = 49.71% ((Revenue TTM 3.07b - Cost of Revenue TTM 1.54b) / Revenue TTM)
Gross Margin QoQ = 56.18% (prev 53.70%)
Tobins Q-Ratio = 2.01 (Enterprise Value 5.35b / Total Assets 2.67b)
Interest Expense / Debt = 5.01% (Interest Expense 70.3m / Debt 1.40b)
Taxrate = 23.57% (70.6m / 299.3m)
NOPAT = 282.5m (EBIT 369.6m * (1 - 23.57%))
Current Ratio = 1.83 (Total Current Assets 1.15b / Total Current Liabilities 627.3m)
Debt / Equity = 2.27 (Debt 1.40b / totalStockholderEquity, last quarter 618.5m)
Debt / EBITDA = 3.18 (Net Debt 1.34b / EBITDA 422.0m)
Debt / FCF = 3.17 (Net Debt 1.34b / FCF TTM 423.2m)
Total Stockholder Equity = 583.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.95% (Net Income 267.9m / Total Assets 2.67b)
RoE = 45.96% (Net Income TTM 267.9m / Total Stockholder Equity 583.0m)
RoCE = 21.62% (EBIT 369.6m / Capital Employed (Equity 583.0m + L.T.Debt 1.13b))
RoIC = 13.94% (NOPAT 282.5m / Invested Capital 2.03b)
WACC = 7.71% (E(4.01b)/V(5.41b) * Re(9.07%) + D(1.40b)/V(5.41b) * Rd(5.01%) * (1-Tc(0.24)))
Discount Rate = 9.07% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -72.35 | Cagr: -0.98%
[DCF] Terminal Value 77.97% ; FCFF base≈373.7m ; Y1≈428.3m ; Y5≈630.4m
[DCF] Fair Price = 149.0 (EV 9.49b - Net Debt 1.34b = Equity 8.14b / Shares 54.7m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.07 | EPS CAGR: 12.10% | SUE: 3.58 | # QB: 1
Revenue Correlation: 80.23 | Revenue CAGR: 7.59% | SUE: -0.04 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.32 | Chg30d=-0.83% | Revisions=-10% | Analysts=10
EPS current Year (2026-12-31): EPS=5.29 | Chg30d=+0.04% | Revisions=+70% | GrowthEPS=-5.4% | GrowthRev=-14.3%
EPS next Year (2027-12-31): EPS=6.57 | Chg30d=-0.12% | Revisions=+42% | GrowthEPS=+24.3% | GrowthRev=+4.1%
[Analyst] Revisions Ratio: +42% (up=17, down=6)